Schizophrenia and Related Disorders

DIRECTOR:

Alexander Miller, M.D.

MISSION:

The Division of Schizophrenia and Related Disorders conducts research into biological and psychosocial factors in organizing and conducting many of the Department’s teaching and clinical efforts in these disorders.

PERSONNEL:

Faculty in the Division include Alexander L. Miller, M.D. (Chief), Albana Dassori, M.D., Dawni Velligan, Ph.D., and David C. Glahn, Ph.D.

EDUCATIONAL PROGRAMS:

TBA

RESEARCH PROGRAMS:

Source: NIMH
Title: 1 R01 MH61775-01A2 Compensating for Cognitive Deficits in Schizophrenia
Period: 12/01/01—11/30/06

Source: NIMH
Title: 1 R01 MH62850-01 Medication Adherence and Outcomes in Schizophrenia
Period: 9/30/00—10/31/05

Source: National Alliance for Research on Schizophrenia and Depression (NARSAD)
Title: Assessing the Neurophysiologic Correlates of Contextual Processing Defects in Schizophrenia
Period: 7/01/02—6/30/05

Source: Johnson & Johnson Pharmaceuticals
Title: A study of two does of galantamine HBR as an adjunctive treatment to Risperdal in male outpatients with schizophrenia and associated cognitive deficits, Protocol GAL-SCH-201.
Period:

PATIENT SERVICES:

For new patient evaluation, please call 210.567.5555